Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Bortezomib × Clear all

NCT00425750 2011-11-16

Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

25 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms